SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Richardson who wrote (176)6/26/1997 5:20:00 PM
From: Rudy Saucillo   of 305
 
Dave, unfortunately, I think you spoke too soon. IMUL has just announced cancellation of their 1997 Ragweed trial due to additional info requested by the FDA. This is, obviously, another in a long string of flashing red lights for investors. This additional 1 year delay in the Allervax program could well be the end of it. I hope no one is seriously hurt by the news, but investors have had plenty of warning signs in both the Ragweed and Cat projects over the past year. Rudy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News